Heliox is a low density gas mixture of helium and oxygen commonly used in deep diving (> 6 ATM). This mixture has been also used for clinical purposes, particularly in the critical care setting. Due to of its physical proprieties, Heliox breathing reduces air flow resistances within the bronchial tree; in patients with obstructive lung diseases Heliox may also reduce the work of breathing and improve pulmonary gas exchange efficiency. Beneficial effects have been documented in severe asthma attacks and in patients with chronic obstructive pulmonary disease. A reduction in WOB during mechanical ventilation and an increase in exercise endurance capacity have also been described in COPD. Heliox has been also used in the treatment of upper airways obstruction, bronchiolitis and bronchopulmonary dysplasia. Despite the encouraging results, Heliox use in routine practice remains controversial because of technical implications and high costs.

Clinical use of Heliox in Asthma and COPD / G., Valli; P., Paoletti; Savi, Daniela; Martolini, Dario; Palange, Paolo. - In: MONALDI ARCHIVES FOR CHEST DISEASE. - ISSN 1122-0643. - 67:3(2007), pp. 159-164. [10.4081/monaldi.2007.488]

Clinical use of Heliox in Asthma and COPD

SAVI, DANIELA;MARTOLINI, DARIO;PALANGE, Paolo
2007

Abstract

Heliox is a low density gas mixture of helium and oxygen commonly used in deep diving (> 6 ATM). This mixture has been also used for clinical purposes, particularly in the critical care setting. Due to of its physical proprieties, Heliox breathing reduces air flow resistances within the bronchial tree; in patients with obstructive lung diseases Heliox may also reduce the work of breathing and improve pulmonary gas exchange efficiency. Beneficial effects have been documented in severe asthma attacks and in patients with chronic obstructive pulmonary disease. A reduction in WOB during mechanical ventilation and an increase in exercise endurance capacity have also been described in COPD. Heliox has been also used in the treatment of upper airways obstruction, bronchiolitis and bronchopulmonary dysplasia. Despite the encouraging results, Heliox use in routine practice remains controversial because of technical implications and high costs.
2007
airway resistance; asthma; chronic obstructive; copd; drug effects; heliox; helium; humans; mechanical ventilation; methods; oxygen; oxygen inhalation therapy; pharmacology/therapeutic use; physiopathology/therapy; pulmonary disease; work of breathing
01 Pubblicazione su rivista::01a Articolo in rivista
Clinical use of Heliox in Asthma and COPD / G., Valli; P., Paoletti; Savi, Daniela; Martolini, Dario; Palange, Paolo. - In: MONALDI ARCHIVES FOR CHEST DISEASE. - ISSN 1122-0643. - 67:3(2007), pp. 159-164. [10.4081/monaldi.2007.488]
File allegati a questo prodotto
File Dimensione Formato  
Valli_Clinical_2007.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 82.59 kB
Formato Adobe PDF
82.59 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/401540
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 13
  • ???jsp.display-item.citation.isi??? ND
social impact